Most Community-Based Oncologists Skip Biomarker Testing Most Community-Based Oncologists Skip Biomarker Testing

Fewer than half of community oncologists use biomarker testing to guide patient discussions about treatment, compared with 73% of academic clinicians.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news